A review of the in situ probe designs from recent Ice Giant mission concept studies.

For the Ice Giants, atmospheric entry probes provide critical measurements not attainable via remote observations. Including the 2013-2022 NASA Planetary Decadal Survey, there have been at least five comprehensive atmospheric probe engineering design studies performed in recent years by NASA and ESA. International science definition teams have assessed the science requirements, and each recommended similar measurements and payloads to meet science goals with current instrument technology. The probe system concept has matured and converged on general design parameters that indicate the probe would include a 1-meter class aeroshell and have a mass around 350 to 400-kg. Probe battery sizes vary, depending on the duration of a post-release coast phase, and assumptions about heaters and instrument power needs. The various mission concepts demonstrate the need for advanced power and thermal protection system development. The many completed studies show an Ice Giant mission with an in situ probe is feasible and would be welcomed by the international science community.

[The regulatory framework for complementary and alternative medicines in Europe]. / Europäische Gesetzgebung zu besonderen Therapierichtungen.

Medicinal products from complementary and alternative medicine are in Germany a regular part of the health care system. Herbal, homeopathic, anthroposophic and traditional medicinal products are highly accepted by the population. The German Medicines Act obliged the competent authorities to consider the particular characteristics of complementary and alternative medicines. The European regulatory framework defined the status of herbal medicinal products, traditional herbal medicinal products and homeopathic medicinal products within the directive 2001/83/EC. The committee for herbal medicinal products (HMPC) was established at the European Medicines Agency in London (EMEA); for homeopathic medicinal products there is a specific working group established by the Heads of Medicines Agencies. Harmonisation of medicinal products from complementary and alternative and traditional medicine in Europe was enforced by implementation of directive 2001/83/EC in national legislations of member states. The provisions of this directive will substantially influence the development of the European market during the forthcoming years.